Lilly hungry enough for less-mega deals

Eli Lilly chief John Lechleiter may not be up for a mega-merger, but he is looking for acquisitions of as much as $15 billion now that Lilly has digested ImClone Systems. "I got hungry again about three weeks after ImClone got closed" in late November, Dr. Lechleiter told the Wall Street Journal. Report